Preconference Programming


About Preconference Sessions

Get a jump start on Congress and join us in DC a day early! You can earn four additional CNE contact hours by attending preconference sessions. Add preconference sessions to your full Congress registration or choose to attend preconference sessions only.

Register Now

Preconference Pricing

 

Registration Type Price (Per Session)
Member $99
Nonmember $189

Session Information

 

Wednesday, May 16

13 PM 

 

Managing Moral Distress and Building Resiliency

Healthcare organizations often implement programs and support systems to reduce the risk of moral distress. However, the reality is that work in oncology will continue to put nurses at risk. The key to prevailing over moral distress is learning how to recognize it and develop strategies to build moral resiliency. Moral resilience allows oncology nurses to cope with the challenging situations they face each day, process the complex stressors involved, and retain emotional and spiritual stability. Join us as we discuss moral distress in oncology nursing, examine the biology and science behind this condition, and explore the tools and methods available for building moral resiliency at the staff, unit, and organizational level.

Skills Lab: Lab Interpretations for Oncology Nurses

Attendees will learn how to interpret abnormal lab results in both solid tumor and hematology malignancy-based cancer patients. Case studies will be used to discuss how to best follow up with patients whose labs are trending in a negative way or those who need immediate follow up because of an oncologic emergency. This session will be helpful for both novice nurses who are new to oncology and advanced practice nurses who want a review.

Improving Patient Outcomes Through Physical Activity Assessment and Education

Cancer survivors across the disease trajectory report many benefits from being physically active, including reductions in cancer-related symptoms such as fatigue, anxiety, and depression and improvement in cognitive functioning. It can also improve cardiovascular function, strength and quality of life. Despite the known benefits of physical activity, many nurses are not comfortable talking with patients about physical activity and may not know where to begin. Attendees will learn tools to assess physical activity levels and simple exercises designed for cancer survivors by a trained expert in helping people with cancer become more active. There will also be opportunities to practice these exercises and role-play. In addition, course facilitators will provide mentorship to help attendees address barriers to integration of physical activity into their practice setting, including ongoing support after the conference ends.


 

3:305:30 PM 

 

USP Chapter <800> Standards for Hazardous Drug Safety: Practical Aspects of Implementation

USP General Chapter <800> is an important step forward for oncology nurse safety. It describes practice and quality standards for handling hazardous drugs (HDs). The safe handling of HDs is essential to reducing exposure and promoting patient safety, healthcare worker safety, and environmental protection. Successful implementation of the standards requires nurses to be informed about the requirements, recognize the need for ongoing HD education and training, and identify and implement safety equipment and procedures. The goal of this session is to provide an overview of the USP Chapter <800> standards, with emphasis on those standards that directly impact nursing. The presenters will offer practical recommendations for achieving compliance through the use of examples and case studies.

Immuno-Oncology: How to Develop a Treatment Plan

Immunotherapy is becoming more prevalent for cancer treatment.  Many of the initial agents were oral, but injectable agents, such as those engineered agents created from a patient’s own cells, are becoming more common. What do you need to know in order to talk with your patients about this treatment option? How do you prep your patient for these options if they will not be administered at your facility? Join us in this session to discuss an immunotherapy plan of treatment from initial identification of this treatment option, to insurance clearance, actual treatment, and ongoing follow up.

 


*Schedule is tentative and subject to change.